Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve ...

Integra Lifesciences today announced it named Mojdeh Poul as president and CEO, effective January 6, 2025.

R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...

Boston Scientific will purchase Ajax Health's Cortex and its OptiMap system to guide physicians performing AFib-treating ...

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).

The investment, announced Oct. 24, makes Ottoback (Duderstadt Germany) the largest shareholder in Onward Medical (Eindhoven, The Netherlands).

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Whiting succeeds Jill Schiaparelli, who served in the corner office since 2018. He takes over at the Columbus, Ohio-based non-invasive neuromodulation technology developer advancing a therapy for ...

Quanta Dialysis Technologies announced today that it received FDA 510(k) clearance for the use of its dialysis system in the home.

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...